{"transactions":[{"id":724103,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-29T20:37:30.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2027 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":5860,"derivative":{"exercise_price":5.5,"expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001610717-26-000303","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071726000303/form4.xml","form_type":"4"}},{"id":779927,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-14T21:45:56.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."}],"balance_after":22500,"derivative":{"exercise_price":11.61,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001629627-26-000003","document":"form4-05142026_090552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000162962726000003/form4-05142026_090552.xml","form_type":"4"}},{"id":1101096,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-26T20:29:23.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":5860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2026 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":5860,"derivative":{"exercise_price":7.63,"expiration_date":"2035-06-25","underlying":"Common Stock","underlying_shares":5860},"source":{"system":"sec-edgar","filing":"0001610717-25-000254","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071725000254/form4.xml","form_type":"4"}},{"id":1116877,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-10T20:51:49.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 6, 2026 or the date immediately prior to the Issuer's 2026 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":3.83,"expiration_date":"2035-06-06","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0000950170-25-084420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000095017025084420/ownership.xml","form_type":"4"}},{"id":1143968,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-19T20:10:06.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 15, 2025 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 15, 2025 and monthly thereafter for so long as the reporting person remains a director of  the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."}],"balance_after":22500,"derivative":{"exercise_price":16.05,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001415889-25-013612","document":"form4-05192025_040503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588925013612/form4-05192025_040503.xml","form_type":"4"}},{"id":1467279,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T20:07:03.000Z","date":"2024-06-27","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2025 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-06-27","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-24-000369","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000369/form4.xml","form_type":"4"}},{"id":1501066,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-28T20:28:10.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 23, 2024 and monthly thereafter for so long as the reporting person remains a director of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 23, 2024 and monthly thereafter for so long as the reporting person remains a director of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service."}],"balance_after":22500,"derivative":{"exercise_price":7.85,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001415889-24-014671","document":"form4-05282024_080506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588924014671/form4-05282024_080506.xml","form_type":"4"}},{"id":1612457,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:29:13.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":8823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's shares granted to the reporting person on November 16, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 8,823 shares, having an exercise price of $0.96 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary."}],"balance_after":8823,"derivative":{"exercise_price":0.96,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":8823},"source":{"system":"sec-edgar","filing":"0001610717-24-000094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000094/form4.xml","form_type":"4"}},{"id":1612456,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-28T22:29:13.000Z","date":"2024-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's shares granted to the reporting person on November 16, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 8,823 shares, having an exercise price of $0.96 per share."}],"balance_after":0,"derivative":{"exercise_price":16.52,"exercise_date":"2021-12-16","expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001610717-24-000094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071724000094/form4.xml","form_type":"4"}},{"id":1668492,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-29T19:07:33.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of 18 months from the grant date or the date immediately prior to the Issuer's 2025 annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":4.55,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-24-002333","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919124002333/doc4.xml","form_type":"4"}},{"id":1824892,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-22T01:06:01.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2024 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-23-000217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000161071723000217/form4.xml","form_type":"4"}},{"id":1855489,"issuer":{"id":95793,"kind":"organization","name":"POINT Biopharma Global Inc.","symbol":"PNT"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T22:15:29.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":80503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest 100% on the first anniversary of the grant date."}],"balance_after":80503,"derivative":{"exercise_price":10.08,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":80503},"source":{"system":"sec-edgar","filing":"0001104659-23-071303","document":"tm2318760-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629627/000110465923071303/tm2318760-1_4seq1.xml","form_type":"4"}},{"id":1861206,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:15:42.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of June 7, 2024 or the date immediately prior to the Issuer's next annual meeting of stockholders."}],"balance_after":31500,"derivative":{"exercise_price":6,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":31500},"source":{"system":"sec-edgar","filing":"0001209191-23-035793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919123035793/doc4.xml","form_type":"4"}},{"id":2221259,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-27T20:11:56.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or immediately prior to the annual meeting in 2023 of the Issuer's stockholders, subject to continuous service to the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-22-013387","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761922013387/doc1.xml","form_type":"4"}},{"id":2250056,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T20:10:44.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":4400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of May 31, 2023 or the date immediately prior to the Issuer's next annual meeting of stockholders."}],"balance_after":4400,"derivative":{"exercise_price":6.9,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":4400},"source":{"system":"sec-edgar","filing":"0001209191-22-033135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919122033135/doc4.xml","form_type":"4"}},{"id":2505011,"issuer":{"id":7352,"kind":"organization","name":"Aligos Therapeutics, Inc."},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T21:38:24.000Z","date":"2021-11-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares vest in thirty-six (36) successive and equal monthly installments measured from November 16, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":30000,"derivative":{"exercise_price":16.52,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-21-020770","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799448/000156761921020770/doc1.xml","form_type":"4"}},{"id":2783920,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-17T20:56:03.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":5650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in monthly installments over 36 months commencing one month from March 15, 2021."}],"balance_after":5650,"derivative":{"exercise_price":12.1,"expiration_date":"2031-03-15","underlying":"Common Stock","underlying_shares":5650},"source":{"system":"sec-edgar","filing":"0001209191-21-021393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000120919121021393/doc4.xml","form_type":"4"}},{"id":3276843,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Acting Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2020-02-12T21:22:13.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest on the one year anniversary of the date of grant, and 1/48th of the shares vest in 36 monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":12.22,"expiration_date":"2030-02-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-008730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120008730/doc4.xml","form_type":"4"}},{"id":3276842,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Acting Chief Medical Officer"}}],"security":"Option to purchase common stock","published_at":"2020-02-12T21:22:13.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":12.22,"expiration_date":"2030-02-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-008730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120008730/doc4.xml","form_type":"4"}},{"id":4398957,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-07T17:01:09.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":74900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant."}],"balance_after":74900,"derivative":{"exercise_price":5.15,"expiration_date":"2024-03-03","underlying":"Common Stock; $0.01 par value per share","underlying_shares":74900},"source":{"system":"sec-edgar","filing":"0001209191-17-018801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117018801/doc4.xml","form_type":"4"}},{"id":4398956,"issuer":{"id":164322,"kind":"organization","name":"JUNIPER PHARMACEUTICALS INC","symbol":"JNP"},"owners":[{"id":34837,"kind":"person","name":"Martell Bridget A","position":1,"cik":"0001629627","reported_name":"Martell Bridget A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-07T17:01:09.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Restricted Stock Unit Award shall vest 25% on each anniversary of the date of grant over 4 years."}],"balance_after":15500,"source":{"system":"sec-edgar","filing":"0001209191-17-018801","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/821995/000120919117018801/doc4.xml","form_type":"4"}}]}